News

Go back

Jul 28, 2022 - Pharmacy

Medicines – new document from EMA on titanium dioxide

On July 1, 2022, the EMA (European Medicines Agency) published a new document with questions and answers regarding the use of titanium dioxide (TiO2) in medicines.

The background is the ban of the compound as a food additive (E171). Despite the provisional approval of titanium dioxide for medicines, the industry is urged to seek alternatives.

The total of 5 questions and answers provide advice on how to deal with this substance in medicines in the future.

Do you have regulatory questions about medicines?

Feel free to contact your customer advisor. In the network of the international Tentamus laboratory group, we can support you with all regulatory issues in the pharmaceutical sector.

Source:

EMA via link